This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Concept
|
Fluorouracil
|
|
Academic Article
|
Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C.
|
|
Academic Article
|
Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer.
|
|
Academic Article
|
Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
|
|
Academic Article
|
Phase I study of interleukin-2 combined with interferon-alpha and 5-fluorouracil in patients with metastatic renal cell cancer.
|
|
Academic Article
|
5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.
|
|
Academic Article
|
Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
|
|
Academic Article
|
Chemotherapy of carcinoma of renal pelvis: preliminary report.
|
|
Academic Article
|
The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.
|
|
Academic Article
|
Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP).
|
|
Academic Article
|
Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors.
|
|
Academic Article
|
Management of pelvic complications of malignant urothelial tumors with combined intra-arterial and iv chemotherapy.
|
|
Academic Article
|
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
|
|
Academic Article
|
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.
|
|
Academic Article
|
A phase I study of FAP (5-Fluorouracil, a-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies.
|
|
Academic Article
|
A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies
|
|
Academic Article
|
Doxorubicin, mitomycin-C, 5-fluorouracil (DMF) in the therapy of hormonal resistant adenocarcinoma of the prostate
|